title: Psilocybin for depression and anxiety associated with life-threatening illnesses.
authors.affiliation: Department of Pharmacology, Division of Chemical Biology and Medicinal Chemistry and the National Institute of Mental Health Psychoactive Drug Screening Program, University of North Carolina Chapel Hill Medical School, Chapel Hill, NC, USA.
authors.forename: John D
authors.initials: JD
authors.lastname: McCorvy
authors.affiliation: Department of Pharmacology, Division of Chemical Biology and Medicinal Chemistry and the National Institute of Mental Health Psychoactive Drug Screening Program, University of North Carolina Chapel Hill Medical School, Chapel Hill, NC, USA.
authors.forename: Reid Hj
authors.initials: RH
authors.lastname: Olsen
authors.affiliation: Department of Pharmacology, Division of Chemical Biology and Medicinal Chemistry and the National Institute of Mental Health Psychoactive Drug Screening Program, University of North Carolina Chapel Hill Medical School, Chapel Hill, NC, USA bryan_roth@med.unc.edu.
authors.forename: Bryan L
authors.initials: BL
authors.lastname: Roth
mesh_terms: D001007:Anxiety; D003863:Depression; D003866:Depressive Disorder; D006213:Hallucinogens; D006801:Humans; D011562:Psilocybin
chemical_list: D006213:Hallucinogens; D011562:Psilocybin